Professor David Price
Chair of Primary Care Respiratory Med
- About
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 8 of 37 Results 176 to 200 of 924
Sustained Improvement in Clinical Efficacy, Asthma Control, and Quality of Life in Patients With Severe, Oral Corticosteroid (OCS)-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
EAACI HYBRID CONGRESS 2022, pp. 237Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1111/all.15616
- [OPEN ACCESS] http://aura.abdn.ac.uk/bitstreams/5a1d0c1c-beba-498f-b422-2e805eb22112/download
An observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma
ThoraxContributions to Journals: ArticlesClinical recommendations for dry powder inhaler use in the management of COPD in primary care
npj Primary Care Respiratory Medicine, vol. 32, 59Contributions to Journals: ArticlesCommencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients
Contributions to Conferences: Oral PresentationsSystemic Corticosteroids in Asthma: A Call to Action From World Allergy Organization and Respiratory Effectiveness Group
World Allergy Organization Journal, vol. 15, no. 12, 100726Contributions to Journals: ArticlesAdrenal function recovery after durable OCS-sparing with benralizumab in the PONENTE study
European Respiratory Journal, vol. 60, no. 6, 2103226Contributions to Journals: ArticlesBiomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma
European Respiratory Society (ERS) International Congress., 2814Contributions to Journals: AbstractsBurden of severe asthma by biologic use and eligibility: an analysis of the International Severe Asthma Registry
European Respiratory Society (ERS) International Congress., 2143Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1183/13993003.congress-2022.2143
Carbon footprint of inhalers in respiratory treatment: SABA CARBON International
European Respiratory Society (ERS) International Congress., 2901Contributions to Journals: AbstractsCharacterising the impact of sex on severe asthma (SA) in the UK Severe Asthma Registry (UKSAR)
European Respiratory Society (ERS) International Congress., 308Contributions to Journals: AbstractsCommencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients
European Respiratory Society (ERS) International Congress., pp. 1552Contributions to Journals: AbstractsMortality outcomes associated with oral corticosteroid use in patients with COPD
European Respiratory Society (ERS) International Congress., 1819Contributions to Journals: AbstractsOver-the-counter (OTC) short-acting β2-agonist (SABA) purchase and asthma outcomes in SABINA III
European Respiratory Society (ERS) International Congress., 3434Contributions to Journals: AbstractsPatient-reported barriers to accepting a technological adherence package in the MAGNIFY trial
European Respiratory Society (ERS) International Congress., 3402Contributions to Journals: AbstractsPersistent reductions in OCS use in patients with severe, OCS dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study
World Allergy Congress 2022, pp. 383Contributions to Journals: AbstractsReal-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
European Respiratory Society (ERS) International Congress., 3305Contributions to Journals: AbstractsRisk factors for corticosteroid- and antibiotic only-treated asthma attacks in the NOVELTY cohort
European Respiratory Society (ERS) International Congress., 2125Contributions to Journals: AbstractsWhat have we learnt from real-life research in asthma and COPD?: Standards and novel designs for the future
Respirology, vol. 27, no. 12, pp. 1018-1021Contributions to Journals: Comments and Debates- [ONLINE] DOI: https://doi.org/10.1111/resp.14381
Effectiveness of initiating biologics in severe asthma patients with high steroid exposure
European Respiratory Society (ERS) International Congress., 3405Contributions to Journals: AbstractsProactive Risk Management: A Novel Approach to Embedding Oral Corticosteroid Stewardship into Asthma Care
European Medical Journal - Respiratory, vol. 10, no. Supplement 2Contributions to Journals: ArticlesAdverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study
British Thoracic Society Winter Meeting 2022, pp. A54Contributions to Conferences: AbstractsS88 Adverse outcomes following initiation of oral corticosteroids for chronic obstructive pulmonary disease: long-term observational study
Thorax, vol. 77, no. Suppl. 1, pp. A54Contributions to Journals: AbstractsP186 Facilitators to recruiting COPD patients to an adherence intervention trial
Thorax, vol. 77, no. Suppl. 1, A182Contributions to Journals: Abstracts- [ONLINE] DOI: https://doi.org/10.1136/thorax-2022-BTSabstracts.320
Poor adherence in exacerbating COPD patients: magnitude and related factors at baseline in the MAGNIFY pragmatic trial
British Thoracic Society Winter Meeting 2022, pp. A72-A73Contributions to Journals: AbstractsDupilumab Treatment Leads to Sustained Reductions in Oral Corticosteroid Use in Patients With Oral Corticosteroid-Dependent Severe Asthma
CHEST 2022, pp. A1909-A1913Contributions to Journals: Abstracts